Company intelligence / Profile preview

Meitheal Pharmaceuticals

Chicago, Illinois, United Statesmeithealpharma.com ↗

Ownership: Private
Development stage: Commercial

Overview

Meitheal has successfully launched multiple generic injectable medications including liraglutide injection recently approved by the FDA to address shortages[7]. They have ongoing clinical trials for biologic therapies including monoclonals and insulin biosimilars with plans to expand their portfolio significantly by end of year[1][3][6].

Therapeutic areas: ImmunologyEndocrinologyWomen's HealthOncologyInfectious Diseases
Modalities: Small moleculesBiosimilarsBiologicsInjectable generics
Industry: Biotech

Drug pipeline

1 asset

recombinant human follicle stimulating hormone

Approved

Partnerships

Strategic global partnerships with FDA-approved manufacturers/R&D partners across Europe, India, China[1]Licensing agreement for YUSIMRY® adalimumab biosimilar from Coherus BioSciences[6]Partnership with Premier on COVID‑19 research[1]

Beyond the preview

Go deeper on Meitheal Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meitheal Pharmaceuticals.

Explore the full profile